Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Operating Income (2018 - 2019)

Historic Operating Income for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$2.8 million.

  • DiaMedica Therapeutics' Operating Income fell 3084.55% to -$2.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$11.6 million, marking a year-over-year decrease of 7149.41%. This contributed to the annual value of -$26.7 million for FY2024, which is 2545.73% down from last year.
  • Per DiaMedica Therapeutics' latest filing, its Operating Income stood at -$2.8 million for Q4 2019, which was down 3084.55% from -$2.7 million recorded in Q3 2019.
  • DiaMedica Therapeutics' 5-year Operating Income high stood at -$1.3 million for Q1 2018, and its period low was -$3.4 million during Q1 2019.